| Ticker: COGE | 300 Oser Avenue | |
| Exchange: NASDAQ-Small Cap Market | Hauppauge, New York 11788 | |
| Industry: Manufacturing | (800) 342-6555 |
| Type of Shares: | Common Shares | Filing Date: | 12/21/95 | |
| U.S. Shares: | 690,000 | Offer Date: | 3/6/96 | |
| Non-U.S. Shares: | 0 | Filing Price: | $5.00 | |
| Primary Shares: | 690,000 | Offer Price: | $5.00 | |
| Secondary Shares: | 0 | Gross Spread: | $0.50 | |
| Offering Amount: | $3,450,000 | Selling: | $0.25 | |
| Expenses: | $600,500 | Reallowance: | ||
| Shares Out After: | 3,690,000 | |||
| Spin out parent firm: | Walpac, Inc. | |||
| Manager | Tier | Phone |
| VTR Capital, Inc. | Lead Manager | (303) 756-0909 |
| Auditor: Holtz Rubenstein & Co. | |||||
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 10/31/95 | 10/31/95 | ||||
| Revenue: | $0.00 | Assets: | $2.05 | ||
| Net Income: | $0.20 | Liabilities: | $0.81 | ||
| EPS: | -$0.07 | Equity: | $1.24 | ||
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company is engaged in the distribution, marketing and sale of dietary supplements and over the counter non-prescription pharmaceuticals. The company distributes its products under company owned trademarks through direct sales to major wholesalers, particularly those that service convenience stores, drug stores, discount department stores, wholesale clubs, petroleum marketers, hospital gift shops and airport gift shops supported by a sophisticated broker network. The company focuses its marketing efforts on a gravity fed display containing the Compare Generiks label products which are comparable to the thirteen top national brand non prescription products sold in the market today. A gravity fed display is designed to restock the shelf display automatically as each unit of product is removed. On October 31, 1995, the company acquired from PDK Labs, Inc. certain assets and rights relating to the Energex Plus product line, including all interest in the Energex Plus market, customer list, trade secrets, trademarks, and trade names, including the use of the tradename "energex Plus". In addition, concurrently the company also acquired from PDK all the assets and rights relating to the "Compare Generiks" product line. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used for marketing and advertising; repayment of certain indebtedness, and working capital. |
©1996 IPO Data Systems, Inc. - All rights reserved.